Housley and his team are developing self‑assembling nanohydrogels that deliver cancer drugs only when they reach tumor‑specific conditions, aiming to reduce side effects and make treatment more precise across multiple cancer types.

When Postdoctoral Research Fellow Hannah Youngblood’s work on exfoliation glaucoma (XFG) was featured by the BrightFocus Foundation, it caught the attention of Jennifer Rucker, an Alabama resident who was diagnosed with XFG several years ago.

Georgia Tech and the Nell Hodgson Woodruff School of Nursing at Emory University are partnering to develop a pipeline that prepares more local nurses to meet workforce demands.

Georgia Tech researchers analyze seasonal differences of SO₂ and sulfate concentrations in the atmosphere over decades to determine the long-term impact of sustained air quality control efforts.

RNA’s Surprising Role in DNA Repair New insights could lead to improved treatments for cancer and other diseases.

The miniature models could exponentially accelerate vaccine development, cancer treatment research, and improved health outcomes across a spectrum of diseases.

BME researchers combine precision and simplicity in cell-free biosensors, transforming diagnostic tools.

Newly discovered antibodies break down the protein that causes glaucoma.

Measles can damage the lungs and immune system, and also inflict permanent brain damage.

Insights could not only pave the way for new treatment strategies for genetic disorders, cancer and neurodegenerative diseases, but also enhance gene-editing technologies.